The latest Mendelian randomization analysis also found that IGF-I polymorphism has a causal relationship with the risk of prostate cancer (r=1.12, P = 0.004), suggesting that IGF-I affects the occurrence of prostate cancer at the genetic level (1). Here, IGF1 is linked to prostate carcinoma.